Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
40% of Aussie and NZ firms ignore skin cancer risk assessments, risking liability and millions in lost productivity.
A new whitepaper reveals that 40% of Australian and New Zealand organizations never assess employee skin cancer risks despite acknowledging a duty of care, exposing directors to liability.
Untreated skin cancer could cost New Zealand $648 million in productivity over 26 years, with higher losses expected in Australia.
Early detection improves survival—98% at Stage 0 versus as low as 24% at advanced stages—and annual screenings costing $100–200 per employee are far cheaper than one missed workday at $600.
The report urges companies to treat skin checks as a core duty under health and safety and ESG standards, requiring formal risk assessments, diagnostic tools, and measurable outcomes.
MoleMap, with over 25 years of experience and 53+ clinics, offers workplace screening programs to support compliance and employee health.
El 40% de las firmas australianas y neozelandesas ignoran las evaluaciones de riesgo de cáncer de piel, arriesgando responsabilidad y millones en pérdida de productividad.